Bristol-Myers Squibb

Executive Summary

Bruce Ross to president, BMS U.S. Pharmaceuticals Group, responsible for the Squibb U.S. Pharmaceutical businesses, Bristol-Myers Oncology Division, Mead Johnson Labs, and medical, marketing, business development and sales services function supporting the pharmaceutical businesses. He reports to Ray Egan, president BMS U.S. Pharmaceuticals, Mead Johnson Nutritionals, Squibb Diagnostics, and Managed Health Care Group. A 29-year veteran who started with Bristol Labs in 1971, Ross became president of Bristol-Myer's U.S. Pharmaceutical Group in 1987. Reporting to him is James Mauzey, who was named president of the BMS U.S. Pharmaceutical Division. Mauzey joined the firm in 1989 from Lederle and most recently had been president of the Squibb U.S. Pharmaceutical Group.